Biological Storage Facility - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Biological Storage Facility


Vindon’s UK storage suite based in Rochdale offers 2000 cubic meters of controlled environment storage space, providing pharmaceutical stability storage at all World Climatic ICH conditions as well as bespoke conditions.

Biological storage at low and ultra-low temperatures is available at temperatures from -20ºC to -80ºC. Vindon’s Ultra-low temperature facility can store millions of samples, vials or tube racks and annual validation and servicing by our in-house engineers ensures the most reliable storage solution.

Vindon’s HTA licensed Cryobank uses DryStore freezers for cryogenic storage at minus 190ºC, vapour phase storage systems designed to ensure against sample contamination. Our state of the art biorepository provides secure storage for stem cells, cord stem cells, biological samples, DNA and Bone Marrow.

Vindon Scientific also has IMB-certified storage facilities in Tramore, Ireland and storage suites in Kennesaw, near Atlanta, Georgia in the USA and from mid 2013 in Orange County, California, USA.

On-site engineers monitor equipment and undertake preventive maintenance with back-up generators providing additional security in the event of power failure.

Vindon engineers offer a full Validation and Calibration service using a combination of UKAS (United Kingdom Accreditation Service) calibrated equipment and state-of-the-art data acquisition systems, Vindon’s qualified and experienced engineers are extensively trained in the validation and calibration of any make/model of environmental chamber as well as our own Vindon manufactured product.

Vindon UK

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here